Companies Johnson & Johnson FollowOct 3 (Reuters) - A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson (JNJ.N) in a trial over four plaintiffs' claims that they developed cancer from being exposed to the company's talc powder products. The Superior Court of New Jersey Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors in the case. Reporting By Brendan Pierson in New York; editing by Jonathan OatisOur Standards: The Thomson Reuters Trust Principles.

---

Persons: Johnson, Brendan Pierson, Jonathan Oatis Organizations: Johnson, of New, of New Jersey Appellate Division, Thomson Locations: Jersey, of New Jersey, New York